OFFICIAL LEGAL TITLE
Recognizing the importance of a continued commitment to ending pediatric HIV/AIDS worldwide.
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 119_HRES_955.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2025-12-17.
What are the main provisions?
Key points include:
- Strengthening global programs aimed at preventing mother-to-child transmission (PMTCT) of HIV.
- Supporting access to new, long-acting preventative methods for pregnant and breastfeeding women globally.
- Increased focus on scaling up treatment for children and adolescents living with HIV, including better access to age-appropriate medicines.
- Encouraging the PEPFAR program to develop a dedicated, standalone pediatric HIV strategy aligned with global goals.
What is the specific legal status?
The current status is Introduced.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. McClellan, Jennifer L. [D-VA-4].
What is the latest detailed status?
The latest detailed status is: Submitted in House
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-02-05.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.